Sanofi India launches re-usable insulin pen ‘AllStar’

09 Oct 2012 Evaluate

Sanofi India (formerly known as Aventis Pharma) has launch of AllStar, its first indigenously manufactured re-usable insulin pen. Developed especially for Indian patients by Sanofi’s Medical Device Development team at Frankfurt, AllStar, is indicated for use of insulinized patients using Sanofi’s insulin portfolio. The AllStar re-usable insulin pen conforms to ISO (International Organization for Standardization) standards and is equipped with state-of-the-art, unparalleled 10-in-1 features.

AllStar is custom-made for patients in India. It helps improve both insulin initiation and compliance and brings ease and reassurance to the lives of Indian patients, giving them the convenience of international standards at an affordable price. Further, the launch of AllStar is a significant milestone in Sanofi India’s diabetes growth story, and also underlines the Sanofi Group’s focus on diabetes, emerging markets and its regionalized approach to finding solutions that are adapted to local needs.

Sanofi India Share Price

6052.95 -28.20 (-0.46%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.